Al Hammadi Holding announces its Interim Financial results for the Period Ending on 2025-03-31 ( Three Months )
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 301.88 | 277.04 | 8.966 | 322.79 | -6.477 |
| Gross Profit (Loss) | 96.51 | 91.06 | 5.985 | 109.61 | -11.951 |
| Operational Profit (Loss) | 76.73 | 74.9 | 2.443 | 78.65 | -2.441 |
| Net profit (Loss) | 73.93 | 64.04 | 15.443 | 77.76 | -4.925 |
| Total Comprehensive Income | 75.24 | 64.31 | 16.995 | 78.96 | -4.711 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Total Shareholders Equity (after Deducting Minority Equity) | 1,980.5 | 1,853.23 | 6.867 |
| Profit (Loss) per Share | 0.46 | 0.4 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is | The revenues for the first quarter of 2025 increased by 9.0% year-on-year to reach 301.88 million Saudi Riyals (compared to 277.04 million Saudi Riyals in the first quarter of 2024), and this increase is primarily due to:
1) Increase in revenues of the medical services segment. 2) Increase in revenues of the pharmaceutical products segment. |
| The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is | During the first quarter of 2025, net profit increased by an annual rate of 15.4% to reach 73.93 million Saudi Riyals, accompanied by an improvement in the net profit margin to 24.5% compared to 23.1% in the corresponding quarter of the previous year. This growth in net profit is primarily attributed to:
1) The 9.0% increase in net revenue for the current quarter compared to the same quarter of the previous year. 2) During the current quarter, the company recorded finance income of 2.03 million Saudi Riyals due to an increase in its cash balance and improved collection efficiency. 3) The increase in the share of profits from the associate company to reach 5.49 million Saudi Riyals during the current quarter. |
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is | First-quarter 2025 revenues fell by 6.5% year-on-year to 301.88 million Saudi Riyals (down from 322.79 million Saudi Riyals in Q4 2024). This decline is primarily attributed to decreased revenues in the medical services segment as the current quarter aligned with the holy month of Ramadan. |
| The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is | The current quarter's net profit declined by 4.9% to 73.93 million Saudi Riyals (from 77.76 million Saudi Riyals in the prior quarter) due to:
1) A decrease in net revenues for the current quarter by 6.5% compared to the fourth quarter of the previous year. 2) Selling and marketing expenses rose by 2.81 million Saudi Riyals this quarter compared to the last, due to increased advertising and promotional efforts. 3) The company recorded an estimated Zakat expense of 4.00 million Saudi Riyals in the current quarter, contrasting with a 0.12 million Saudi Riyal surplus in the Zakat provision in the prior quarter. |
| Statement of the type of external auditor's report | Unmodified conclusion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | None |
| Reclassification of Comparison Items | None |
| Additional Information | None |
Comments